Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia.
Stewart
Daniel G
DG
Mount Sinai School of Medicine, Department of Psychiatry, New York, NY 10029, USA.
Davis
Kenneth L
KL
D000367:Age Factors; D000818:Animals; D003711:Demyelinating Diseases / Q000150:complications; D003952:Diagnostic Imaging / Q000379:methods; D018260:Gelsolin / Q000235:genetics / Q000378:metabolism; D015870:Gene Expression; D008040:Genetic Linkage; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism; D009186:Myelin Sheath / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D018992:Myelin-Associated Glycoprotein / Q000235:genetics / Q000378:metabolism; D009457:Neuroglia / Q000502:physiology; D009836:Oligodendroglia / Q000378:metabolism* / Q000473:pathology; D020893:Receptor, ErbB-3 / Q000235:genetics / Q000378:metabolism; D012559:Schizophrenia / Q000209:etiology / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D014168:Transferrin / Q000235:genetics / Q000378:metabolism
D018260:Gelsolin; D018992:Myelin-Associated Glycoprotein; D014168:Transferrin; D020893:Receptor, ErbB-3